| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.22 | 0.2 |